Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | MGAM | O43451 | 1/20 | 0.37 |
| ▸ | SI | P14410 | 1/20 | 0.37 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MPI | P34949 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.33 |
| ▸ | TOP1 | P11387 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1428140 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1MGAMSI | |
| SCHEMBL2318762 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1MGAMSI | |
| SCHEMBL287865 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1MGAMSI | |
| SCHEMBL557541 | 1.00 | LMNA (0.39) | LMNAL3MBTL1TDP1MGAMSI | |
| SCHEMBL19859337 | 0.88 | MPI (0.34) | LMNAL3MBTL1MGAMSIMPI | |
| SCHEMBL19859338 | 0.88 | MPI (0.34) | LMNAL3MBTL1MGAMSIMPI | |
| SCHEMBL3142523 | 0.88 | AKR1B1 (0.37) | LMNAL3MBTL1AKR1B1MPI | |
| SCHEMBL5453628 | 0.88 | AKR1B1 (0.37) | LMNAL3MBTL1AKR1B1MPI | |
| SCHEMBL183626 | 0.88 | AKR1B1 (0.37) | LMNAL3MBTL1AKR1B1MPI | |
| SCHEMBL5770928 | 0.88 | AKR1B1 (0.37) | LMNAL3MBTL1AKR1B1MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115998760-B | Application of Pleurotus citrinopileatus polysaccharide in preparing anti-inflammatory drugs | 河南大学 | 2024-01-26 | — | — | CN | claimed |
| CN-117384308-A | Radix tetrastigme polysaccharide prepared based on Phellinus fermentation and application thereof | 浙江省林业科学研究院 | 2024-01-12 | — | — | CN | claimed |
| CN-114591448-B | Mulberry and phellinus linteus fruiting body manna galactosan and preparation and application thereof | 浙江省林业科学研究院 | 2023-06-06 | — | — | CN | claimed |
| CN-114591448-A | Phellinus igniarius sporophore mannogalactan and preparation and application thereof | 浙江省林业科学研究院 | 2022-06-07 | — | — | CN | claimed |
| CN-111655298-A | Diagnostic formulation for magnetic resonance of neoplastic diseases comprising deuterated 3-O-methylglucose and diagnostic method using said formulation | 索尔维克斯有限公司 | 2020-09-11 | — | — | CN | claimed |
| CN-117384308-B | Radix tetrastigme polysaccharide prepared based on Phellinus fermentation and application thereof | 浙江省林业科学研究院 | 2026-02-03 | — | — | CN | disclosed |
| US-20250161428-A1 | PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2025-05-22 | — | — | US | disclosed |
| EP-4490181-A1 | PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION | National Research Council of Canada (CA) | 2025-01-15 | — | — | EP | disclosed |
| CN-119095871-A | Prevention/treatment of pseudomonas aeruginosa infection | 加拿大国家研究委员会 | 2024-12-06 | — | — | CN | disclosed |
| CN-115998760-B | Application of Pleurotus citrinopileatus polysaccharide in preparing anti-inflammatory drugs | 河南大学 | 2024-01-26 | — | — | CN | disclosed |
| CN-117384308-A | Radix tetrastigme polysaccharide prepared based on Phellinus fermentation and application thereof | 浙江省林业科学研究院 | 2024-01-12 | — | — | CN | disclosed |
| CN-117384308-A | Radix tetrastigme polysaccharide prepared based on Phellinus fermentation and application thereof | 浙江省林业科学研究院 | 2024-01-12 | — | — | CN | disclosed |
| WO-2023168520-A1 | PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION | NATIONAL RESEARCH COUNCIL OF CANADA (CA) | 2023-09-14 | — | — | WO | disclosed |
| CN-114591448-B | Mulberry and phellinus linteus fruiting body manna galactosan and preparation and application thereof | 浙江省林业科学研究院 | 2023-06-06 | — | — | CN | disclosed |
| CN-114591448-B | Mulberry and phellinus linteus fruiting body manna galactosan and preparation and application thereof | 浙江省林业科学研究院 | 2023-06-06 | — | — | CN | disclosed |
| CN-115998760-A | Application of Pleurotus citrinopileatus polysaccharide in preparing anti-inflammatory drugs | 河南大学 | 2023-04-25 | — | — | CN | disclosed |
| CN-114591448-A | Phellinus igniarius sporophore mannogalactan and preparation and application thereof | 浙江省林业科学研究院 | 2022-06-07 | — | — | CN | disclosed |
| CN-114591448-A | Phellinus igniarius sporophore mannogalactan and preparation and application thereof | 浙江省林业科学研究院 | 2022-06-07 | — | — | CN | disclosed |
| US-5585473-A | Compounds and methods for monosaccharide analysis | THE BIOMEMBRANE INSTITUTE (US) | 1996-12-17 | — | — | US | disclosed |
| CN-85107903-A | Produce the method for antibiotic A40926 complex and pure factors PA.PB.A.B. and B0 | — | 1987-05-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250161428-A1 | PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION | SIGLEC7, CD47, SELP | LMNA 4850/4885L3MBTL1 2022/4885TDP1 4764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.